TBRG 📈 TruBridge - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2053061030

TBRG: Healthcare, Solutions, Services, Technology, Consulting, Management

TruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence. The company provides acute care solutions and related services for community hospitals, and physician clinics; and patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. In addition, it offers patient liability estimates eligibility verification, claim scrubbing and submission, remittance management, denial/audit management, and contract management; and offers RCM services, such as accounts receivable management, private pay service, medical coding, revenue cycle consulting, and other additional insurance and patient billing services. Further, it offers consulting and business management services; managed IT services; encoder solutions; patient management; financial accounting; clinical; patient care; and enterprise applications. Additionally, it offers TruBridge HER platform, including total system support, national client conference, continuing education, software releases, hardware replacement, cloud electronic health record, forms and supplies, and public cloud infrastructure services; post-acute care software systems, and support and maintenance services; and InstantPHR, an interactive portal and CHBase which funnels data from multiple sources into one platform. The company was formerly known as Computer Programs and Systems, Inc. and changed its name to TruBridge, Inc. in March 2024. TruBridge, Inc. was founded in 1979 and is headquartered in Mobile, Alabama. Web URL: https://www.trubridge.com

Additional Sources for TBRG Stock

TBRG Stock Overview

Market Cap in USD 277m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Technology
IPO / Inception 2002-05-21

TBRG Stock Ratings

Growth 5y -27.6%
Fundamental -39.0%
Dividend 8.41%
Rel. Strength Industry 2511
Analysts 3.75/5
Fair Price Momentum 19.75 USD
Fair Price DCF -

TBRG Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y -100.00%
Payout Consistency 69.7%

TBRG Growth Ratios

Growth Correlation 3m 94.5%
Growth Correlation 12m 79%
Growth Correlation 5y -52%
CAGR 5y -7.58%
CAGR/Mean DD 5y -0.25
Sharpe Ratio 12m 1.06
Alpha 39.26
Beta 0.87
Volatility 37.00%
Current Volume 134.6k
Average Volume 20d 66k
What is the price of TBRG stocks?
As of December 22, 2024, the stock is trading at USD 18.19 with a total of 134,615 shares traded.
Over the past week, the price has changed by -1.86%, over one month by +9.71%, over three months by +46.34% and over the past year by +60.88%.
Is TruBridge a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, TruBridge (NASDAQ:TBRG) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -38.99 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TBRG as of December 2024 is 19.75. This means that TBRG is currently overvalued and has a potential downside of 8.58%.
Is TBRG a buy, sell or hold?
TruBridge has received a consensus analysts rating of 3.75. Therefor, it is recommend to hold TBRG.
  • Strong Buy: 1
  • Buy: 1
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for TBRG stock price target?
According to ValueRays Forecast Model, TBRG TruBridge will be worth about 21.4 in December 2025. The stock is currently trading at 18.19. This means that the stock has a potential upside of +17.87%.
Issuer Forecast Upside
Wallstreet Target Price 16 -12%
Analysts Target Price 25.3 39.3%
ValueRay Target Price 21.4 17.9%